Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00239343

Femme Homme

Extrait

The aim of the study is to estimate the effect of preoperative gefitinib on the complete pathological response rate in primary estrogen receptor negative breast cancer at the time of surgery.


Critère d'inclusion

  • Breast Cancer

Liens